Copyright: ©Author(s) 2026.
World J Gastrointest Endosc. Apr 16, 2026; 18(4): 118261
Published online Apr 16, 2026. doi: 10.4253/wjge.v18.i4.118261
Published online Apr 16, 2026. doi: 10.4253/wjge.v18.i4.118261
Table 1 Patient characteristics, mean ± SD/median (interquartile range)
| Propofol combination therapy | Propofol monotherapy | P value | |
| Intervention | 2.5 mg midazolame + propofol | Propofol monotherapy | |
| Number of patients | 60 (female 30, male 30) | 60 (female 29, male 31) | |
| Age (years) | 55.5 (50-69) | 57 (50-69) | 0.96 |
| BMI (kg/m2) | 25.4 ± 3.37 | 26 ± 3.03 | 0.33 |
Table 2 Relevant results, mean ± SD
| Propofol combination therapy | Propofol monotherapy | P value | |
| Dose of propofol (mg) | 65 ± 21 | 217 ± 61 | < 0.01 |
| Duration of examination (minute) | 21.4 ± 6 | 18.6 ± 6 | 0.02 |
| Duration until discharge (minute) | 49.4 ± 17 | 57.7 ± 26 | 0.04 |
Table 3 Costs per patient (Euro)
| Propofol combination therapy | Propofol monotherapy | P value | |
| Mean cost per mililiter | 2.87 | 8.01 | < 0.01 |
| Mean costs per 5 mL syringe propofol | 3.69 | 8.55 | < 0.01 |
| Mean costs per 10 mL syringe propofol | 4.31 | 9.20 | < 0.01 |
- Citation: Ott C, Dobsch P, Sander M, Schnoy E, Pawlik MT. Moderate sedation with midazolam and propofol is as safe as propofol monotherapy for colonoscopy, but more cost-effective. World J Gastrointest Endosc 2026; 18(4): 118261
- URL: https://www.wjgnet.com/1948-5190/full/v18/i4/118261.htm
- DOI: https://dx.doi.org/10.4253/wjge.v18.i4.118261
